These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 18385197

  • 1. Health information styles among participants in a prostate cancer screening informed decision-making intervention.
    Williams-Piehota PA, McCormack LA, Treiman K, Bann CM.
    Health Educ Res; 2008 Jun; 23(3):440-53. PubMed ID: 18385197
    [Abstract] [Full Text] [Related]

  • 2. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
    O'Dell KJ, Volk RJ, Cass AR, Spann SJ.
    J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
    [Abstract] [Full Text] [Related]

  • 3. A community-based intervention to promote informed decision making for prostate cancer screening among Hispanic American men changed knowledge and role preferences: a cluster RCT.
    Chan EC, McFall SL, Byrd TL, Mullen PD, Volk RJ, Ureda J, Calderon-Mora J, Morales P, Valdes A, Kay Bartholomew L.
    Patient Educ Couns; 2011 Aug; 84(2):e44-51. PubMed ID: 21237611
    [Abstract] [Full Text] [Related]

  • 4. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
    Watson E, Hewitson P, Brett J, Bukach C, Evans R, Edwards A, Elwyn G, Cargill A, Austoker J.
    Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
    [Abstract] [Full Text] [Related]

  • 5. Promoting prostate-specific antigen informed decision-making. Evaluating two community-level interventions.
    Driscoll DL, Rupert DJ, Golin CE, McCormack LA, Sheridan SL, Welch BM, Poehlman JA.
    Am J Prev Med; 2008 Aug; 35(2):87-94. PubMed ID: 18617077
    [Abstract] [Full Text] [Related]

  • 6. Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.
    van Vugt HA, Roobol MJ, Venderbos LD, Joosten-van Zwanenburg E, Essink-Bot ML, Steyerberg EW, Bangma CH, Korfage IJ.
    Eur J Cancer; 2010 Feb; 46(3):669-77. PubMed ID: 20022239
    [Abstract] [Full Text] [Related]

  • 7. Randomized trial examining the effect of two prostate cancer screening educational interventions on patient knowledge, preferences, and behaviors.
    Partin MR, Nelson D, Radosevich D, Nugent S, Flood AB, Dillon N, Holtzman J, Haas M, Wilt TJ.
    J Gen Intern Med; 2004 Aug; 19(8):835-42. PubMed ID: 15242468
    [Abstract] [Full Text] [Related]

  • 8. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
    Hoffman RM, Couper MP, Zikmund-Fisher BJ, Levin CA, McNaughton-Collins M, Helitzer DL, VanHoewyk J, Barry MJ.
    Arch Intern Med; 2009 Sep 28; 169(17):1611-8. PubMed ID: 19786681
    [Abstract] [Full Text] [Related]

  • 9. The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men.
    Hevey D, Pertl M, Thomas K, Maher L, Chuinneagáin SN, Craig A.
    Patient Educ Couns; 2009 Feb 28; 74(2):244-9. PubMed ID: 18848753
    [Abstract] [Full Text] [Related]

  • 10. Prostate cancer screening and informed decision-making: provider and patient perspectives.
    Bowen DJ, Hannon PA, Harris JR, Martin DP.
    Prostate Cancer Prostatic Dis; 2011 Jun 28; 14(2):155-61. PubMed ID: 21243007
    [Abstract] [Full Text] [Related]

  • 11. Provision of individualized information to men and their partners to facilitate treatment decision making in prostate cancer.
    Davison BJ, Goldenberg SL, Gleave ME, Degner LF.
    Oncol Nurs Forum; 2003 Jun 28; 30(1):107-14. PubMed ID: 12515988
    [Abstract] [Full Text] [Related]

  • 12. Men considering a hypothetical treatment for prostate cancer: a comparison to patients.
    Van Manen L, Feldman-Stewart D, Brundage MD.
    Patient Educ Couns; 2006 Apr 28; 61(1):33-42. PubMed ID: 16257170
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evidence-based patient choice: a prostate cancer decision aid in plain language.
    Holmes-Rovner M, Stableford S, Fagerlin A, Wei JT, Dunn RL, Ohene-Frempong J, Kelly-Blake K, Rovner DR.
    BMC Med Inform Decis Mak; 2005 Jun 20; 5():16. PubMed ID: 15963238
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Unwanted control: how patients in the primary care setting decide about screening for prostate cancer.
    Woolf SH, Krist AH, Johnson RE, Stenborg PS.
    Patient Educ Couns; 2005 Jan 20; 56(1):116-24. PubMed ID: 15590232
    [Abstract] [Full Text] [Related]

  • 19. Perceptions of informed consent by participants in a prostate cancer prevention study.
    Gotay CC.
    Cancer Epidemiol Biomarkers Prev; 2001 Oct 20; 10(10):1097-9. PubMed ID: 11588137
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.